Healthspan podcast

94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

10/7/2024
0:00
11:00
Rewind 15 seconds
Fast Forward 15 seconds

@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.

More episodes from "Healthspan"